Hypertension and the Heart: Proceedings of an International Conference Held As Part of the Menarini Series on Cardiovascular Diseases in Berlin, Germany, February 27-28, 1997

by Fondazione Internazionale Menarini, International Congress on Hypertension and the Heart, Alberto Zanchetti (Editor), Lennart Hansson (Editor), Richard B Devereux (Editor)

Overview

Session I: Left Ventricular Hypertrophy: Structural Aspects and Mechanisms.- 1. Relations of Left Ventricular Geometry and Function to Prognosis in Hypertension.- 2. Left Ventricular Hypertrophy, Arterial Compliance, and Aging.- 3. Left Ventricular Hypertrophy and Arterial Blood Pressure in Experimental Models of Hypertension.- 4. Regulation and Role of Myocardial Collagen Matrix Remodeling in Hypertensive Heart Disease.- 5. Ultrasonic Reflectivity of the Heart: A Measure of Fibrosis?.- 6. Local Angiotensin II and Myocardial Fibrosis.- 7. Left Ventricular Anatomy and Function in Primary Aldosteronism and Renovascular Hypertension.- Session II: Pathophysiological and Molecular Aspects.- 8. Hypertension Differentially Affects the Expression of the Gap Junction Protein Connexin43 in Cardiac Myocytes and Aortic Smooth Muscle Cells.- 9. Modulation of Cardiac Hypertrophy by Estrogens.- 10. Salt Sensitivity and Left Ventricular Hypertrophy.- 11. Volume Overload, Atrial Natriuretic Peptide, and Left Ventricular Hypertrophy.- 12. The Renin-Angiotensin System Gene Polymorphism and Left Ventricular Hypertrophy.- 13. Renin-Angiotensin System Gene Polymorphisms and Left Ventricular Hypertrophy: The Case against an Association.- Session III: Pathophysiological and Therapeutic Aspects.- 14. Left Ventricular Hypertrophy and Arterial Hypertrophy.- 15. Relationship between Cardiac Hypertrophy and Microalbuminuria.- 16. Physiological versus Pathological Hypertrophy: The Athlete and the Hypertensive.- 17. Bradykinin and Cardiac Protection.- 18. Left Ventricular Hypertrophy and Sympathetic Activity.- 19. Hypertension, Left Ventricular Hypertrophy, and Heart Rate Variability.- 20. Comparison of Meta-Analyses of Therapeutic Studies on Regression of Left Ventricular Hypertrophy.- 21. Comparison of Therapeutic Studies on Regression of Left Ventricular Hypertrophy.- 22. Prognostic Significance of Left Ventricular Hypertrophy Regression.- Session IV: Myocardial Ischemia.- 23. Hypertension and Coronary Microvascular Disease.- 24. Myocardial Perfusion in Hypertensive Patients with Normal Coronary Arteries.- 25. Endothelial Dysfunction in Hypertension.- 26. Endothelial Dysfunction in Hypertensives: An Uncertain Association.- 27. Hypertension, Left Ventricular Hypertrophy, and Coronary Flow Reserve.- 28. Hypertensive Heart Disease, Ventricular Dysrhythmias, and Sudden Death.- 29. Hypertension and Heart Failure.- Speakers.

Product Details

ISBN-13:	9780306457746
Publisher:	Springer-Verlag New York, LLC
Publication date:	12/28/1997
Series:	Advances in Experimental Medicine and Biology Series , #432
Edition description:	New Edition
Pages:	288
Product dimensions:	6.69(w) x 9.61(h) x 0.69(d)

About the Author

Zanchetti, Alberto (Univ of Milan); Devereux, Richard B. (Cornell Univ); Hansson, Lennart (Univ of Uppsala); Gorini, Sergio (International Menarini Foundation, Milan)

Editorial Reviews

Reviewer: John F. Moran, MD (Loyola University Stritch School of Medicine)
Description: This is a report on proceedings of a hypertension symposium. The editors cover cardiac hypertrophy from several viewpoints — structural, molecular, pathophysiological, and clinical. This is the 432nd volume in the series on advances in experimental medicine and biology.
Purpose: The purpose is to publish new information on the pathophysiology of hypertension.
Audience: Medical residents, fellows, researchers, and practitioners who are interested in pathophysiology and the basic aspects of hypertension as well as the significance of left ventricular hypertrophy should find this text fascinating.
Features: The book is a good review of the structural changes of left ventricular hypertrophy and the epidemiology that results. Important pathophysiology and clinical aspects of hypertension are also discussed. The references at the end of each chapter are excellent, current, and extensive. The illustrations are all in black-and-white but add to the text. All chapters are relatively short and pertinent. The index is very helpful.
Assessment: This text will be useful for clinicians who are interested in the mechanisms of disease and curious about some of the basic science strategies for reducing left ventricular mass in the presence of hypertension (i.e., use of angiotensin converting enzyme inhibitors). This book is well written. It is not a text of the management of hypertension such as the recent text by Beevers, Hypertension in Practice, 3rd Edition (Martin Dunitz, 1999) or Bohm's From Hypertension to Heart Failure (Springer-Verlag, 1998). I recommend this text, as it meets the editors' goal of presenting new information on hypertension and left ventricular hypertrophy.

Doody's Review Service

3 Stars from Doody

This is a report on proceedings of a hypertension symposium. The editors cover cardiac hypertrophy from several viewpoints -- structural, molecular, pathophysiological, and clinical. This is the 432nd volume in the series on advances in experimental medicine and biology. The purpose is to publish new information on the pathophysiology of hypertension. Medical residents, fellows, researchers, and practitioners who are interested in pathophysiology and the basic aspects of hypertension as well as the significance of left ventricular hypertrophy should find this text fascinating. The book is a good review of the structural changes of left ventricular hypertrophy and the epidemiology that results. Important pathophysiology and clinical aspects of hypertension are also discussed. The references at the end of each chapter are excellent, current, and extensive. The illustrations are all in black-and-white but add to the text. All chapters are relatively short and pertinent. The index is very helpful. This text will be useful for clinicians who are interested in the mechanisms of disease and curious about some of the basic science strategies for reducing left ventricular mass in the presence of hypertension (i.e., use of angiotensin converting enzyme inhibitors). This book is well written. It is not a text of the management of hypertension such as the recent text by Beevers, Hypertension in Practice, 3rd Edition (Martin Dunitz, 1999) or Bohm's From Hypertension to Heart Failure (Springer-Verlag, 1998). I recommend this text, as it meets the editors' goal of presenting new information on hypertension and left ventricular hypertrophy.

John F. Moran

Twenty-nine presentations from an international congress held in February 1997 on the topic of left ventricular hypertrophy as an important and independent risk factor in cases of hypertension. The first section deals with the structural aspects and mechanisms of LVH. Sections two and three cover the pathophysiological and molecular aspects, and pathophysiological and therapeutic aspects of LVH. The final section looks at myocardial ischemia and other complications in hypertension. Annotation c. by Book News, Inc., Portland, Or.

Booknews